Blood Borne Virus Review for Healthcare Professionals
Blood Borne Virus Review for Healthcare Professionals
Hepatitis B
People with chronic Hepatitis B virus (HBV) and/or Hepatitis C virus (HCV) are at risk of serious liver disease such as liver cirrhosis and hepatocellular carcinoma (HCC) and remain infectious to others. Because chronic HBV and HCV infections are typically asymptomatic, notification data reflect national screening and testing practices and do not give accurate insights into the prevalence of infections. Thus, to adequately inform primary or secondary prevention efforts, supplementary information such as prevalence data are needed.
People with chronic Hepatitis B virus (HBV) and/or Hepatitis C virus (HCV) are at risk of serious liver disease such as liver cirrhosis and hepatocellular carcinoma (HCC) and remain infectious to others. Because chronic HBV and HCV infections are typically asymptomatic, notification data reflect national screening and testing practices and do not give accurate insights into the prevalence of infections. Thus, to adequately inform primary or secondary prevention efforts, supplementary information such as prevalence data are needed.
Author: Dr Siamak Tonekaboni
We at BBVReview want to generate awareness about suffering of patients affected by viral hepatitis. As a part of our plan, we intend to publish patient stories where they tell us about not only their pain, but also about successful treatment and their courage and great achievements as human beings.
The story below is about Dee Lee, a hepatitis B carrier who started an awareness and anti-prejudice campaign early in his life. He is now a famous hepatitis elimination campaigner. He is Director of Inno Community Development Organisation and West Pacific Region Board Member of World Hepatitis Alliance. We feel honoured to publish Dee’s story here at BBVReview and thanks him for his contribution.
Targeting the cccDNA episome offers hope of a future cure for HBV. Potential new compounds are outlined in this review but their effectiveness awaits to be demonstrated in on-going clinical studies